Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579202 · ClinicalTrials.gov registry record
Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer
A clinical trial, sponsored by Vantive Health.
- Completed
- Registry status
- 24
- Enrollment target
NCT00579202: Completed study, sponsored by Vantive Health.
NCT00579202 is a clinical trial that has completed, run by Vantive Health. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579202 has completed, sponsored by Vantive Health.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis
Interventions
- DEVICE Gambro HD-C4 Small Dialyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-10 |
| Est. Completion | 2007-11 |
What the finished NCT00579202 record still lists
NCT00579202 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Gambro HD-C4 Small Dialyzer is the first listed.
NCT00579202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579202 about?
NCT00579202 is a clinical study titled "Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer". The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis
What is the current status of trial NCT00579202?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2007-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00579202?
The interventions under investigation include: Gambro HD-C4 Small Dialyzer (DEVICE).
Who is sponsoring clinical trial NCT00579202?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia